bimagrumab glp-1 Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during receptor agonism Antibody blockade of activin type

Combining GLP-1 treatments with biologics

In recent years, GLP-1 role in neuronal pathways has expanded its therapeutic potential

Learn how GLP-1-based therapies like exenatide and liraglutide effectively reduce HbA1c, preserve beta cell function, and promote weight loss in type 2 diabetes.

A ruling by drug watchdog ICER that Novo and Eli Lillys weight-loss drugs are cost-effective could pave the way for new growth.

This JAMA Internal Medicine patient page covers #GLP1 weight-loss medications, focusing on food craving reduction, blood glucose control, dietary strategies, exercise for muscle retention, and lifestyle changes to prevent weight regain.

Many supplements pass through your body with minimal impact